Belite Bio (BLTE) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $142.78, -6.45% vs the prior close of $152.62.
- Volume 177.23K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BLTE slides 6.4% to $142.78, a 3-month low. Closed at $142.78, -6.45% vs the prior close of $152.62. Day range $141.65–$152.62, opened at $152.62.
BLTE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BLTE slides 6.4% to $142.78, a 3-month low
- Closed at $142.78, -6.45% vs the prior close of $152.62. Day range $141.65–$152.62, opened at $152.62.
- Volume was 177.23K shares, 0.9x its 50-day average of 188.98K.
- Price is -13.5% vs its 50-day average ($165.01) and -11.2% vs its 200-day average ($160.84).
- 52-week range $81.01–$200.00; today's close sits at 52% of that range, 28.6% below the 52-week high.
Oct 15, 2026 — BLTE ends flat (-0.1%) to $152.62
- Closed at $152.62, -0.07% vs the prior close of $152.72. Day range $152.13–$155.47, opened at $153.87.
- Volume was 195.90K shares, 1.0x its 50-day average of 187.90K.
- Price is -7.7% vs its 50-day average ($165.37) and -5.2% vs its 200-day average ($160.93).
- 52-week range $79.05–$200.00; today's close sits at 61% of that range, 23.7% below the 52-week high.
Oct 14, 2026 — BLTE rises 0.6% to $152.72
- Closed at $152.72, +0.56% vs the prior close of $151.87. Day range $150.02–$155.09, opened at $151.17.
- Volume was 158.50K shares, 0.8x its 50-day average of 186.84K.
- Price is -7.7% vs its 50-day average ($165.48) and -5.1% vs its 200-day average ($160.99).
- 52-week range $78.71–$200.00; today's close sits at 61% of that range, 23.6% below the 52-week high.
Oct 13, 2026 — BLTE slides 4.2% to $151.87, a 1-month low
- Closed at $151.87, -4.24% vs the prior close of $158.59. Day range $150.93–$161.00, opened at $157.01.
- Volume was 233.40K shares, 1.3x its 50-day average of 186.00K.
- Price is -8.3% vs its 50-day average ($165.57) and -5.7% vs its 200-day average ($161.00).
- 52-week range $78.71–$200.00; today's close sits at 60% of that range, 24.1% below the 52-week high.
Oct 12, 2026 — BLTE rises 2.7% to $158.59
- Closed at $158.59, +2.65% vs the prior close of $154.49. Day range $154.63–$160.74, opened at $154.95.
- Volume was 259.20K shares, 1.4x its 50-day average of 184.00K.
- Price is -4.3% vs its 50-day average ($165.63) and -1.5% vs its 200-day average ($161.02).
- 52-week range $77.64–$200.00; today's close sits at 66% of that range, 20.7% below the 52-week high.
Oct 9, 2026 — BLTE rises 1.3% to $154.49
- Closed at $154.49, +1.29% vs the prior close of $152.52. Day range $152.17–$155.99, opened at $152.73.
- Volume was 179.30K shares, 1.0x its 50-day average of 185.26K.
- Price is -6.7% vs its 50-day average ($165.63) and -4.0% vs its 200-day average ($161.00).
- 52-week range $77.12–$200.00; today's close sits at 63% of that range, 22.8% below the 52-week high.
Oct 8, 2026 — BLTE dips 2.3% to $152.52, a 1-month low
- Closed at $152.52, -2.28% vs the prior close of $156.08. Day range $150.21–$155.85, opened at $155.79.
- Volume was 154.40K shares, 0.8x its 50-day average of 187.00K.
- Price is -8.0% vs its 50-day average ($165.74) and -5.3% vs its 200-day average ($161.00).
- 52-week range $76.50–$200.00; today's close sits at 62% of that range, 23.7% below the 52-week high.
Oct 7, 2026 — BLTE rises 0.3% to $156.08
- Closed at $156.08, +0.30% vs the prior close of $155.61. Day range $154.60–$156.75, opened at $155.09.
- Volume was 97.80K shares, 0.5x its 50-day average of 187.44K — lighter than usual.
- Price is -5.8% vs its 50-day average ($165.74) and -3.1% vs its 200-day average ($161.02).
- 52-week range $76.23–$200.00; today's close sits at 65% of that range, 22.0% below the 52-week high.
Oct 6, 2026 — BLTE dips 2.2% to $155.61, a 1-month low, 4 down days in a row
- Closed at $155.61, -2.24% vs the prior close of $159.18. Day range $152.64–$158.24, opened at $158.24.
- Volume was 190.30K shares, 1.0x its 50-day average of 186.36K.
- Price is -6.1% vs its 50-day average ($165.74) and -3.4% vs its 200-day average ($161.01).
- 52-week range $75.95–$200.00; today's close sits at 64% of that range, 22.2% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — BLTE ends flat (-0.2%) to $159.18, a 1-month low, 3 down days in a row
- Closed at $159.18, -0.24% vs the prior close of $159.56. Day range $156.40–$160.00, opened at $160.00.
- Volume was 133.30K shares, 0.7x its 50-day average of 187.15K.
- Price is -4.0% vs its 50-day average ($165.79) and -1.1% vs its 200-day average ($161.01).
- 52-week range $72.65–$200.00; today's close sits at 68% of that range, 20.4% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — BLTE dips 2.1% to $159.56, a 1-month low
- Closed at $159.56, -2.10% vs the prior close of $162.98. Day range $159.00–$164.60, opened at $163.50.
- Volume was 184.80K shares, 1.0x its 50-day average of 186.53K.
- Price is -3.7% vs its 50-day average ($165.68) and -0.9% vs its 200-day average ($160.96).
- 52-week range $70.80–$200.00; today's close sits at 69% of that range, 20.2% below the 52-week high.
BLTE latest news & SEC filings
Every SEC filing by or about BLTE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Scholl Hendrik Peter sold 200 shares at $163.62 (≈$32.73K) on Oct 1, 2026; now holds 14,800
- Scholl Hendrik Peter sold 24 shares at $164.64 (≈$3.95K) on Oct 1, 2026; now holds 14,776
- Scholl Hendrik Peter sold 120 shares at $165.49 (≈$19.86K) on Oct 1, 2026; now holds 14,656
- Scholl Hendrik Peter sold 50 shares at $166.44 (≈$8.32K) on Oct 1, 2026; now holds 14,606
- Scholl Hendrik Peter sold 78 shares at $167.59 (≈$13.07K) on Oct 1, 2026; now holds 14,528
- Scholl Hendrik Peter sold 12 shares at $168.21 (≈$2.02K) on Oct 1, 2026; now holds 14,516
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lin Yu-Hsin sold 6,058 shares at $196.54 (≈$1.19M) on Sep 8, 2026
- Lin Yu-Hsin sold 8,752 shares at $197.36 (≈$1.73M) on Sep 8, 2026
- Lin Yu-Hsin sold 2,700 shares at $198.09 (≈$534.84K) on Sep 8, 2026
- Lin Yu-Hsin sold 2,400 shares at $194.33 (≈$466.39K) on Sep 8, 2026
- Lin Yu-Hsin sold 6,090 shares at $195.62 (≈$1.19M) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chuang Hao-Yuan sold 2,562 shares at $198.05 (≈$507.40K) on Sep 8, 2026
- Chuang Hao-Yuan sold 2,200 shares at $194.28 (≈$427.42K) on Sep 8, 2026
- Chuang Hao-Yuan sold 4,120 shares at $195.60 (≈$805.87K) on Sep 8, 2026
- Chuang Hao-Yuan sold 4,475 shares at $196.47 (≈$879.20K) on Sep 8, 2026
- Chuang Hao-Yuan sold 4,605 shares at $197.23 (≈$908.24K) on Sep 8, 2026
- Chuang Hao-Yuan sold 2,562 shares at $198.05 (≈$507.40K) on Sep 8, 2026
- …plus 14 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade BLTE
- How much it moves: over the last 20 sessions the average daily move was 1.88% (largest 6.4%).
- Liquidity: about 172.00K shares (≈$24.56M) trade per day on average.
- 52-week position: $142.78 vs a range of $81.01–$200.00 (52% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Hao-Yuan Chuang sold 2,562 shares on Sep 8, 2026.
- Latest filings: 6-K Sep 8, 2026; 6-K Aug 13, 2026; 6-K Aug 11, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BLTE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 152.62 | 152.62 | 141.65 | 142.78 | 177.23K |
| Oct 15, 2026 | 153.87 | 155.47 | 152.13 | 152.62 | 195.90K |
| Oct 14, 2026 | 151.17 | 155.09 | 150.02 | 152.72 | 158.50K |
| Oct 13, 2026 | 157.01 | 161.00 | 150.93 | 151.87 | 233.40K |
| Oct 12, 2026 | 154.95 | 160.74 | 154.63 | 158.59 | 259.20K |
| Oct 9, 2026 | 152.73 | 155.99 | 152.17 | 154.49 | 179.30K |
| Oct 8, 2026 | 155.79 | 155.85 | 150.21 | 152.52 | 154.40K |
| Oct 7, 2026 | 155.09 | 156.75 | 154.60 | 156.08 | 97.80K |
| Oct 6, 2026 | 158.24 | 158.24 | 152.64 | 155.61 | 190.30K |
| Oct 5, 2026 | 160.00 | 160.00 | 156.40 | 159.18 | 133.30K |
| Oct 2, 2026 | 163.50 | 164.60 | 159.00 | 159.56 | 184.80K |
| Oct 1, 2026 | 168.98 | 170.36 | 162.98 | 162.98 | 198.80K |
| Sep 30, 2026 | 167.27 | 172.74 | 167.18 | 169.82 | 142.00K |
| Sep 29, 2026 | 166.72 | 169.52 | 164.41 | 166.66 | 186.90K |
| Sep 28, 2026 | 166.98 | 171.88 | 165.55 | 165.93 | 127.30K |
| Sep 25, 2026 | 171.78 | 172.00 | 167.06 | 167.33 | 123.70K |
| Sep 24, 2026 | 169.00 | 171.50 | 165.56 | 169.44 | 219.00K |
| Sep 23, 2026 | 175.50 | 175.50 | 166.60 | 168.67 | 153.80K |
| Sep 22, 2026 | 173.69 | 178.44 | 173.66 | 175.35 | 204.60K |
| Sep 21, 2026 | 173.00 | 174.99 | 171.13 | 173.40 | 119.80K |
About Belite Bio
Belite Bio (BLTE) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1889109.
BLTE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gary Clark Biddle | Director | Mar 18, 2026 |
| Wan-Shan Chen | Director | Apr 13, 2026 |
| Xiao-Hui Chen | Director | Mar 18, 2026 |
| Hao-Yuan Chuang | Chief Financial Officer | Sep 9, 2026 |
| Yu-Hsin Lin | Chief Executive Officer | Sep 9, 2026 |
| John Michael Longo | Director | Mar 18, 2026 |
| Ita Lu | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hao-Yuan Chuang | Chief Financial Officer | Sep 9, 2026 |
| Yu-Hsin Lin | Chief Executive Officer | Sep 9, 2026 |
| Nathan L. Mata | Chief Scientific Officer | May 8, 2026 |
| Hendrik Peter Scholl | Chief Medical Officer | Jun 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 2,562 | $198.05 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 2,200 | $194.28 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,120 | $195.60 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,475 | $196.47 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,605 | $197.23 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 2,562 | $198.05 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 2,200 | $194.28 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,120 | $195.60 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,475 | $196.47 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,605 | $197.23 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 2,562 | $198.05 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 2,200 | $194.28 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,120 | $195.60 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,475 | $196.47 |
| Sep 8, 2026 | Hao-Yuan Chuang | Sale | 4,605 | $197.23 |
BLTE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BLTE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BLTE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.